Trials / Completed
CompletedNCT05857878
A Study to Test How Well Different Doses of BI 1815368 Are Tolerated by Healthy Men
Safety, Tolerability, and Pharmacokinetics of Multiple Rising Oral Doses of BI 1815368 in Healthy Male Subjects (Single-blind, Randomised, Placebo-controlled, Parallel Group Design)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This trial aims to investigate safety, tolerability, and pharmacokinetics following multiple rising doses of BI 1815368 in healthy male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BI 1815368 | BI 1815368 |
| DRUG | Matching placebo | Matching placebo |
Timeline
- Start date
- 2023-06-23
- Primary completion
- 2024-06-06
- Completion
- 2024-06-06
- First posted
- 2023-05-15
- Last updated
- 2024-11-19
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT05857878. Inclusion in this directory is not an endorsement.